Insmed announced that CFO Sara Bonstein will step down on October 30, 2026, after nearly seven years, ensuring a smooth transition through the Q3 earnings call on October 29. The company reaffirmed its full-year 2026 revenue guidance, expecting $1.25-$1.40 billion from BRINSUPRI and $450-$470 million from ARIKAYCE. Insmed is actively searching for a new CFO and remains focused on growth and profitability with its respiratory therapies and pipeline. The Q3 2026 financial results will be discussed in a conference call on October 29.
Insmed's CFO transition news comes as 37 out of 100 health-sector US stocks on Pluang rose while 39 fell today. For readers following health stocks, here is Pluang's market snapshot as of Oct 05, 2026 16:21 WIB: XRAY (DENTSPLY SIRONA Inc) traded at USD 8.60 with a 1-day change of -0.81% and a typical hold time of 71 days; NVO (Novo Nordisk A/S) at USD 37.02, down 0.80%, hold time 115 days; PHG (Koninklijke Philips NV) at USD 23.73, down 0.79%, hold time 83 days.
Bank of America upgraded DraftKings stock to Buy from Neutral, citing reduced risks from prediction markets and a favorable risk-reward at current prices. DraftKings shares rose 5% following the upgrade, while competitors Flutter Entertainment and MG...
Vertiv has named Michael Resha as Executive Vice President of Manufacturing, Logistics, and Operational Excellence, succeeding Anders Karlborg who moves to a new role. Resha will lead global manufacturing and logistics efforts to scale operations and...
Bitmine increased its Ether (ETH) holdings by 15,112 coins last week, bringing its total to 6,016,414 ETH. This accumulation highlights Bitmine's ongoing investment in Ethereum, signaling confidence in the digital asset's future. The move may influen...
Cerrado Gold (CRDOF) has been upgraded to a Buy rating due to improved production at its Minera Don Nicolas (MDN) mine, which reached 15,415 gold equivalent ounces in Q2, supporting the annual target of 50,000 GEO. However, cost control remains a cha...
Rapid Dose Therapeutics announced it will issue common shares to settle $142,067.63 of accrued interest on its secured convertible notes by October 15, 2026. The notes, originally issued in 2023, bear 18% annual interest payable quarterly in shares a...
